Form D · Other Health Care
Ablative Solutions, Inc.
Wakefield, MA · CIK 0001535723
Offering snapshot reported Nov 26, 2025 · SEC filing
- Reported sold
- $10.4M Offering amount: $45M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 26, 2025 | Initial | $10,407,500 | No comparison | 10 | SEC filing |
| Dec 26, 2024 | Initial | $37,158,690 | No comparison | 88 | SEC filing |
| Jan 30, 2024 | Amendment | $29,333,042 | $16,360,281vs Apr 7, 2023 | 121 | SEC filing |
| Apr 7, 2023 | Initial | $12,972,761 | No comparison | 72 | SEC filing |
| Feb 1, 2021 | Amendment | $54,462,808 | $36,999,882vs Jan 8, 2019 | 105 | SEC filing |
| Jan 8, 2019 | Initial | $17,462,926 | No comparison | 104 | SEC filing |
| Jan 2, 2018 | Initial | $4,010,990 | No comparison | 24 | SEC filing |
| Mar 1, 2017 | Initial | $11,376,064 | No comparison | 88 | SEC filing |
| Nov 12, 2015 | Initial | $2,460,000 | No comparison | 24 | SEC filing |
| Jan 12, 2015 | Amendment | $14,590,000 | $290,000vs Oct 22, 2014 | 149 | SEC filing |
| Oct 22, 2014 | Amendment | $14,300,000 | $4,724,923vs Jan 7, 2014 | 144 | SEC filing |
| Jan 7, 2014 | Initial | $9,575,077 | No comparison | 100 | SEC filing |
| Nov 7, 2013 | Amendment | $7,995,000 | $2,995,000vs Oct 29, 2013 | 98 | SEC filing |
| Oct 29, 2013 | Amendment | $5,000,000 | $2,295,000vs Aug 14, 2013 | 71 | SEC filing |
| Aug 14, 2013 | Amendment | $2,705,000 | $705,000vs May 20, 2013 | 41 | SEC filing |
| May 20, 2013 | Amendment | $2,000,000 | $950,000vs Apr 4, 2013 | 30 | SEC filing |
| Apr 4, 2013 | Initial | $1,050,000 | No comparison | 13 | SEC filing |
| Jun 26, 2012 | Initial | $5,369,383 | No comparison | 72 | SEC filing |
| Mar 29, 2012 | Amendment | $3,050,500 | $1,588,000vs Feb 10, 2012 | 64 | SEC filing |
| Feb 10, 2012 | Initial | $990 | No comparison | 1 | SEC filing |
| Feb 10, 2012 | Amendment | $1,462,500 | $555,000vs Jan 4, 2012 | 34 | SEC filing |
| Jan 24, 2012 | Initial | $500 | No comparison | 1 | SEC filing |
| Jan 4, 2012 | Initial | $5,000 | No comparison | 2 | SEC filing |
| Jan 4, 2012 | Amendment | $907,500 | $450,000vs Nov 29, 2011 | 22 | SEC filing |
| Nov 29, 2011 | Initial | $457,500 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-565128
Source: Form D, filed Nov 26, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven L. Almany | Director |
| Ronald D. Bache | Director, Executive |
| Paul Buckman | Director |
| Louis Cannon | Director |
| Tim A. Fischell | Director, Executive |
| David R Fischell | Director |
| Michael Fulton | Director |
| Vartan E. Ghazarossian | Director, Executive |
| Dale Grogan | Director |
| Nicole Haratani | Executive |
| Nathan Harrington | Director |
| John Kerschen | Director |
| Lisa Mastromattei | Executive |
| Geoff Pardo | Director |
| Brian Rauls | Executive |
| David K. Rosen | Director |
| Kate Rumrill | Director, Executive |
| Andrew Tochterman | Director |
| Phillip D. Torrence | Executive |
| Benjamin Tsai | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
301 Edgewater Place
Wakefield, MA, 01880
Wakefield, MA, 01880